DREW HETZ: Open Payments
NPI 1558956102 · KENOSHA, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,337 in 46 payments from 8 companies in 2025. Trend: 2023 $961 · 2024 $808 · 2025 $1,337
Food & beverage: $1,237Education: $100
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 19 | $490 |
| Optinose US, Inc. | 8 | $248 |
| Regeneron Healthcare Solutions, Inc. | 5 | $215 |
| GENZYME CORPORATION | 8 | $178 |
| SANOFI-AVENTIS U.S. LLC | 1 | $100 |
| AstraZeneca Pharmaceuticals LP | 3 | $65 |
| Paratek Pharmaceuticals, Inc. | 1 | $24 |
| Lilly USA, LLC | 1 | $17 |
Products named: DUPIXENT, NUCALA, Xhance, ZEPBOUND.
Industry payments across WI — which companies pay providers there.
